2024 Virtual Grand Rounds
2024 Virtual Grand Rounds Session 9: May 22, 2024 - What's New and Hot in Rare Diseases and What's New in Wound Care 2024 Update
About
Fall Clinical Virtual Grand Rounds consist of regularly scheduled CME sessions on a variety of dermatological diseases, delivered by the top experts in dermatology. Please join us for this week's session:
Wednesday, May 22, 2024
8 PM ET / 5 PM PT
What's New and Hot in Rare Diseases
What's New in Wound Care Update 2024
Availability
In order to ensure educational material is relevant, educational materials will expire after a certain time period. This course will be available for the following dates:
May 23, 2024
May 23, 2025
Learning Objectives
At the completion of this activity, participants should be better able to:
Summarize current information in wound literature
Apply new information on wound care into your clinical care
Recognize clinical clues for cutaneous manifestations of autoimmune disease
Assess novel and emerging therapies for cutaneous disease
Intended Audience
This activity has been designed for dermatologists, dermatology physician assistants, dermatology nurse practitioners, and other providers involved in the care of patients.
Faculty
Boni Elewski, MD
James Elder Professor and Chair of Dermatology
University of Alabama at Birmingham
Birmingham, AL
Robert Kirsner, MD
Chairman and Harvey Blank Professor
Dr. Phillip Frost Department of Derm & Cutaneous Surgery
Miller School of Medicine - University of Miami
Miami, FL
Ruth Ann Vleugels, MD
Heidi and Scott C. Schuster Distinguished Chair in Dermatology
Brigham and Women's Hospital
Boston, MA
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Institute for Continuing Healthcare Education and CMEsquared. The Institute is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement
The Institute for Continuing Healthcare Education designates this live and enduring activity for a maximum of 0.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosures & Disclaimers
Disclosures are as follows:
Grant/Research Support: Ortho Dermatology
Consultant: Ortho Dermatology
Advisory Board: Abbvie, Molnklycke, Organogenesis, Pfizer, Urgo
Grant/Research Support: Hoth
Advisory Board: Priovant
Consultant: Argenx
Grant/Research Support: Pfizer
The Institute discloses that all relevant conflicts have been satisfactorily mitigated.